home / stock / anix / anix news

ANIX News and Press, Anixa Biosciences Inc. From 10/22/19

Stock Information
Company Name: Anixa Biosciences Inc.
Stock Symbol: ANIX
Market: NASDAQ
Website: anixa.com
Menu
ANIX ANIX Quote ANIX Short ANIX News ANIX Articles ANIX Message Board
Get ANIX Alerts

News, Short Squeeze, Breakout and More Instantly...
ANIX - Anixa Biosciences Announces Abstract Accepted for Presentation at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2019)

SAN JOSE, Calif. , Oct. 22, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced the acceptance of an abstract at the 34 th Annual Meeting of the Society for Immunothera...
ANIX - Anixa Biosciences Appoints Dr. Thomas Schlumpberger as Executive Vice President of Diagnostics to Head Liquid Biopsy Development and Commercialization Efforts

SAN JOSE, Calif. , Oct. 15, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced the appointment of Thomas Schlumpberger , Ph.D., as Executive Vice President, Dia...

ANIX - Anixa Biosciences Names Cancer Vaccine Pioneer Dr. Ian H. Frazer to Scientific Advisory Board

SAN JOSE, Calif. , Oct. 10, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced the appointment of Ian H. Frazer , MD, AC, FRS, FAA, to its Scientific Advisory Board. Dr....

ANIX - Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek(TM) Prostate Cancer Study

SAN JOSE, Calif. , Sept. 23, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that Mohummad Siddiqui , MD, Associate Professor of Surgery at the University of Maryl...
ANIX - Anixa Biosciences Commences Collaboration with Potomac Urology Center on Cchek(TM) Prostate Cancer Study

SAN JOSE, Calif. , Sept. 19, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that Potomac Urology Center, PC ("PUC") has joined its Cchek™ early cancer detect...

ANIX - Anixa Biosciences Congratulates Scientific Advisory Board Member Dr. H. Michael Shepard as a 2019 Lasker Award Honoree

SAN JOSE, Calif. , Sept. 16, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, congratulates H. Michael Shepard , Ph.D., a member of Anixa's Scientific Advisory Board, as a recipient...

ANIX - Anixa Biosciences to Present at Two Upcoming Investor Conferences

SAN JOSE, Calif. , Aug. 26, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced its participation at two upcoming investor conferences in New York City . Manag...
ANIX - Genetic testers rally on insurance coverage for Myriad's GeneSight

Genetic testing services providers are in the green after UnitedHealthcare instituted coverage  for Myriad Genetics' GeneSight test for major depressive disorder. More news on: NeoGenomics, Inc., Invitae Corporation, Biocept, Inc., Healthcare stocks news, Stocks on the move, Read...

ANIX - Anixa Biosciences Announces VA North Texas Health Care System to Join Cchek(TM) Prostate Cancer Study

SAN JOSE, Calif. , July 29, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that the VA North Texas Health Care System and its non-profit affiliate, the Dallas VA Re...

ANIX - Anixa Biosciences Announces Additional Patent Issued on Cancer Detection Technology

SAN JOSE, Calif. , July 24, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that the United States Patent and Trademark Office (USPTO) has issued US Patent No. 10,36...
Previous 10 Next 10